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EVIDENCE BASED NEURO-ONCOLOGY
Intramedullary spinal cord lesions in children
Ummey Hani,1 Sameer Saleem Tebha,2 Saqib Kamran Bakhshi,3 Muhammad Shahzad Shamim4

Abstract
Paediatric intramedullary spinal cord lesions are
uncommon pathologies, prone to result in dismal
prognosis if not managed promptly and aggressively.
While children usually present in good functional grades
compared to adults, early recognition and treatment is
important to improve outcomes. In this review, we
present tumour demographics, patient factors, and
treatment modalities of intramedullary spinal cord lesions
in paediatric patients.
Keywords: intramedullary spinal cord tumors, pediatric,
ependymoma, astrocytoma

Introduction
Tumours of the Central Nervous System (CNS) are the
second most common malignancies in children, after
leukaemias.1 Intramedullary spinal cord tumours (IMSCT),
however, are uncommon and account for only 3-10% of
all CNS tumours, and 30-40% of all spinal cord tumours in
the paediatric population.1-5 These tumours can be
localized or holocord — the latter involving almost the
entire spinal cord from the cervico-medullary junction to
the conus medullaris, and representing a rarer and more
challenging condition to treat.2,4 Clinically, the tumours
present insidiously, are slowly progressive, and may lead
to profound neurologic deficits.2

based on case series, limiting our ability to completely
understand tumour demographics and outcomes.4
Herein, we have reviewed the literature to assess the
incidence, clinical and radiological characteristics, and
management strategies in children with IMSCT and other
spinal cord lesions.

Review of Evidence
In one of the most cited case series of IMSCT published in
1996, Constantini et al., carried out a retrospective analysis
of 27 children under 3 years of age, who presented with
IMSCT at their centre. They reported pain to be the
commonest presenting symptom, followed by motor
weakness, torticollis, and progressive kyphoscoliosis.
Gross total resection (GTR) was achieved in 72% of the
cases, and no surgical mortality was reported. Twenty-four
low-grade (LG) lesions were observed on histopathology,
with astrocytoma being the commonest (n= 12). Out of
the three reported high-grade (HG) lesions, two were

Low grade astrocytoma represents most of the childhood
IMSCT,
closely
followed
by
ependymomas,
haemangioblastomas and gangliogliomas — the latter
more common below age three.2,6 Developmental
tumours such as teratoma, dermoid and epidermoid cysts
are rarer, occurring mostly during first year of life.2 With
advancement in radiology, intraoperative monitoring and
surgical technique; safe and effective treatment strategies
for these tumours are now available.3,4 Surgery remains
the mainstay of treatment and may or may not be
supplemented by adjuvant therapy.1 Most of the available
evidence on the management of IMSCT in children is
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Figure-1: T1 weighted MR image, sagittal section of cervical spine of a 15 years old
girl, showing loss of cervical lordosis, and a hypo-intense signal change in the spinal
cord, extending from C3 till C6, with swelling of the cord.
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Figure-2: T2 weighted MR image of the same girl, showing a hyperintense, sausage
shaped intramedullary lesion, extending from C3 to C6. It is causing expansion of the
spinal cord, and there are hyperintense signal changes in the cord, proximal and distal
to the lesion.

anaplastic astrocytoma, and one glioblastoma.
Encouraging functional outcomes were seen at 76 months
of follow-up, concluding that IMSCT can be radically and
safely removed in children less than 3 years of age.2,6
In 2012, Bansal et al., carried out a retrospective analysis of
82 paediatric patients with IMSCTs, out of which 69.5%
were males (n=57). Epidermoid cysts constituted the
most common type of tumour, followed by low-grade
gliomas and ependymoma. Ependymomas had a higher
amenability for GTR as compared to pilocytic astrocytoma
(43.7% vs. 22.2% respectively). Near-total resection was
achieved for most other pathologies. At the last followup, most patients had improved (n=8) or unchanged (n=
46) functional status, while two patients had worsened.
The authors concluded that pre-operative neurological
status was more predictive of post-operative functional
outcomes than histological grading.7
Babu et al., published a retrospective analysis in 2014, of 46
patients treated for astrocytoma of the spinal cord at their
center. The median age was 15 years, with a male
predominance observed. Pilocytic astrocytoma was the
commonest pathology (41.6%), followed by grade 2 diffuse
astrocytoma (21.7%), anaplastic astrocytoma grade 3
(19.6%) and glioblastoma in the rest. Most patients
presented with pain (45.7%), while dysesthesia/paresthesia
and scoliosis constituted the rest of the presenting
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Figure-3: T1 post-contrast image of the same girl, showing subtle peripheral
enhancement. This lesion was resected, and histopathology was reported as diffuse
astrocytoma grade II.

symptoms. While surgery was the mainstay of treatment,
GTR could only be achieved in 12.5% of the patients. The
study revealed a direct relationship between high tumour
grade, radical resection and significant post-operative
neurological deficits.8
In another retrospective series by Ahmed et al., 55
children with IMSCT were reviewed. Most children
presented with sensory deficit, with cervicomedullary
junction the commonest site on radiology. Low-grade
astrocytoma was the commonest pathology (53%),
followed closely by ependymoma. Most children
underwent sub-total resection for their tumours (62%),
followed by an additional procedure of shunt insertion in
22 patients, for post-operative hydrocephalus. While no
surgical mortality was observed, 27% patients reportedly
developed new or progressive neurological deficit and
47% had a recurrence of the tumour, at a mean of three
months after surgery. Extent of resection and tumour
grade were conclusively reported to influence patient
outcomes.9 In 2015, Kutluk et al., evaluated the pathologic
factors and treatment modalities in paediatric patients
with IMSCTs. In their retrospective review of 36 patients,
aged 7.9 years on average, they reported ependymoma
(52.8%), and astrocytoma (44.4%) as the commonest
tumours. Only three high grade tumours were reported.
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The tumour was primarily located in the thoracic (47%)
and cervical (28%) segments, and surgery was the
mainstay of treatment, with STR and GTR achieved in
most patients (45% and 33% respectively). Adjuvant
radiation and chemotherapy was used to supplement
treatment in 26 and 15 patients, respectively. The 3, 5 and
10 year overall survival rates were 72%, 63% and 56%, and
event free survival rates were 43%, 40% and 40%,
respectively. The authors reported significantly higher
survival rates in patients with low grade tumours,
especially those in the ependymoma group.1
Luksik et al., carried out a large retrospective assessment,
exploring factors that may influence survival in 348
paediatric patients with spinal cord astrocytoma,
recorded in the surveillance, epidemiology, and end
result (SEER) database. Average age for the group was 9.3
years, with a gender predominance for males. Tumours
were majorly WHO grade 2 (20.7%) followed by grades 4,
1, and 3 tumours. Surgery was the primary treatment
modality, with partial resection achieved in 51.7% of the
patients and gross total resection in 28.7%. Radiotherapy
followed as an adjunct in 28.4% patients and the survival
rate for patients at 5 years was 74.8%. Surgical
intervention, especially with GTR, improved survival,
while high grade lesions, application of radiation therapy,
and distant and invasive extension of the tumour
significantly decreased survival. Younger age was shown
to have a protective effect. The authors conclusively
highlighted the need for early diagnosis for better
prognosis.10 In another major study in 2019, Bhimani et
al., analyzed the Paediatric American College of Surgeons
National Surgical Quality Improvement Programme
database, retrospectively for acute surgical risk. In the
group of 139 patients from the registry, predominantly
males (n= 81), and at a mean age of 8.7 years, tumours
mostly arose from the thoracic spine, followed by the
cervical and lumbar spinal regions. Worse preoperative
health status, and a greater proportion of malignant
tumours were noticed with cervical and thoracic IMSCT
populations compared with the lumbar IMSCT
population. Of the 12 readmissions, patients with cervical
IMSCTs returned to the operating room at a significantly
greater rate than did the thoracic and lumbar IMSCT
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populations, mainly due to respiratory problems and
hydrocephalus management. However, the overall acute
surgical risk reportedly remained low.11

Conclusion
Astrocytoma and ependymoma, predominantly lowgrade, constitute the most common intramedullary
IMSCT in children. While modern surgical adjuncts such as
microscopes and intra-operative monitoring have
resulted in improved outcomes over the years,
preoperative neurologic status, remains the most
important predictive factor of prognosis in children, even
more so than tumour grade.
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